175527-01-2

Basic information

• Product Name: benzyl 2(R)-[(4-methoxybenzenesulfonyl)(benzyl)amino]-2[(N-dimethylaminoacetyl)-4-piperidinyl]acetate
• Synonyms: benzyl 2(R)-[(4-methoxybenzenesulfonyl)(benzyl)amino]-2[(N-dimethylaminoacetyl)-4-piperidinyl]acetate
• CAS NO: 175527-01-2
• Molecular Weight: 593.744
• Mol File: 175527-01-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: benzyl 2(R)-[(4-methoxybenzenesulfonyl)(benzyl)amino]-2[(N-dimethylaminoacetyl)-4-piperidinyl]acetate(CAS DataBase Reference)
• NIST Chemistry Reference: benzyl 2(R)-[(4-methoxybenzenesulfonyl)(benzyl)amino]-2[(N-dimethylaminoacetyl)-4-piperidinyl]acetate(175527-01-2)
• EPA Substance Registry System: benzyl 2(R)-[(4-methoxybenzenesulfonyl)(benzyl)amino]-2[(N-dimethylaminoacetyl)-4-piperidinyl]acetate(175527-01-2)

Safety Data

• Hazardous Substances Data: 175527-01-2(Hazardous Substances Data)

Upstream product

• 177702-24-8 benzyl 2-(R)-[(4-methoxybenzenesulfonyl)(benzyl)amino]-2-(4-piperidinyl)acetate 
• 1118-68-9 dimethylaminoacetic acid 
• 1892-57-5 N-(3-dimethylaminopropyl)-N-ethylcarbodiimide 

Relevant articles and documents

ARYLSULFONAMIDO-SUBSTITUTED HYDROXAMIC ACIDS

The invention relates to the compounds of formula I STR1 pharmaceutically acceptable prodrug derivatives and pharmaceutically acceptable salts thereof; methods for preparation thereof; pharmaceutical compositions comprising said compounds; and a method of inhibiting matrix-degrading metalloproteinase and of treating matrix-degrading metalloproteinase dependent conditions in mammals using such compounds.